EP3542790

NOVO NORDISK
Application Number
EP18212576A
Filing Date
Mar 15, 2013
Status
Granted And Under Opposition
Aug 11, 2023
Grant Date
Sep 13, 2023
External Links
Slate, Register, Google Patents
Similar Patents facing opposition

Bibliography

The patent EP3542790B1 was granted to Novo Nordisk on Sep 13, 2023 following the initial filing on Mar 15, 2013 under the application number EP18212576A . The current legal status of the patent is Granted And Under Opposition.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (7)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

ADALVOJun 13, 2024ADMISSIBLE
CMS CAMERON MCKENNA NABARRO OLSWANGJun 13, 2024ADMISSIBLE
GENERICS UKJun 13, 2024ADMISSIBLE
HEXALJun 13, 2024ADMISSIBLE
KRAUS & LEDERER PARTGMBBJun 13, 2024ADMISSIBLE
POLPHARMAJun 13, 2024ADMISSIBLE
STRAWMANJun 12, 2024ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents